期刊文献+

食管癌根治术后放射治疗 被引量:4

Postoperative irradiation after radical surgery of esophageal carcinoma
下载PDF
导出
摘要 目的 :探讨食管癌根治术后放射治疗的价值。方法 :1989年 1月— 1994年 6月对 80例食管癌根治术后行术后预防性放疗 ,用配对法与同期单纯手术治疗 80例食管癌进行对比 ,放疗剂量 40— 5 0Gy。结果 :单纯手术组一、三、五年生存率为 76 3%、37 5 %、2 2 5 %。手术放疗组一、三、五年生存率为 77 5 %、5 6 3%、32 5 % ,两组三年生存率有显著性意义 (P <0 0 5 ) ,无淋巴结转移者术后放疗组五年生存率较单纯手术组明显提高 ,有显著差异 (P <0 0 1) ,淋巴结阳性者一、三、五年生存率两组无统计学意义。术后放疗组原发灶复发率为 12 5 % ,单纯手术组为42 5 % ,有显著差异 (P <0 0 1)。结论 :术后放疗后复发率低 ,无淋巴结转移者术后应放疗 。 Purpose:To evaluate radiotherapy after operation of esophageal carcinoma. Methods:A comparative study was done between the group of 80 patients treated by postoperative radiotherapy and the group of 80 patients by operation only from January 1989 to June 1994. The radiation dose was 40—50 Gy. Results:The 1 ,3 ,and 5 year survival rates of operative group were 76.3%, 37.5%, 22.5%, and those of postoperative radiotherapy were 77.5 %,56.3 %,32.5 %. There was significant difference between the 3 year survival rates of the two groups ( P <0 05). In the patients without lymph ndoes metastases,5 year survival rates were markedly higher in the group of patients treated by operation with postoperative radiotherapy than in the group of patients treated by operation only ( P <0 01). For patients with lymph nodes metastase, there was no significant difference between the two groups. The recurrence rate of the primary disease was obviously lower in those who received postoperative radiotherapy than those who did not ( P <0 01).Conclusions:The incidence of recurrence is lower in those who received postoperative radiotherapy than those who did not.The patients without lymph nodes metastase should be irradiated after operation. The 3 year survival rate is higher in patients who received postoperative irradition. [
出处 《中国癌症杂志》 CAS CSCD 2001年第1期65-66,共2页 China Oncology
关键词 食管肿瘤 手术后 放射治疗 根治术 esophageal tumor postoperative radiotherapy
  • 相关文献

参考文献2

共引文献19

同被引文献60

  • 1万均.食管癌的放射治疗[M].北京:原子能出版社,2000.107-111. 被引量:1
  • 2Ilson DH. Oesophageal caneer: new developments in systemic therapy [J]. Cancer Treat Rev,2003,29(6) :525 -532. 被引量:1
  • 3Anderson SE ,Minsky BD, Bains M ,et al. Combined modality therapy in esophageal cancer: the Memorial experience [ J]. Semin Surg Oncol, 2003,21 (4) : 228 - 232. 被引量:1
  • 4Scheithauer W. Esophageal cancer: chemotherapy as palliative therapy [ J ]. Ann Oncol,2004,15 ( Suppl 4) : iv 97 - iv 100. 被引量:1
  • 5Koshy M, Esiashvilli N, Landry JC, et al. Multiple management modal- ities in esophageal cancer: combined modality management approaches [ J ]. Oncologist, 2004,9 ( 2 ) : 147 - 159. 被引量:1
  • 6Westerterp M, Koppert LB, Buskens C J, et al. Outcome of surgical treatment for early adenocarcinoma of the esophagus or gastro-esophageal junction [ J ]. Virchows Arch, 2005,446 ( 5 ) : 497 - 504. 被引量:1
  • 7Kaklamanos IG,Walker GR, Ferry K, et al. Neoadjuvant treatment for resectable cancer of the esophagus and the gastroesophageal junction: a meta-analysis of randomized clinical trials [ J ]. Ann Surg Oncol, 2003,10(7) :754 -761. 被引量:1
  • 8Urschel JD, Vasan H, Blewett CJ. A meta-analysis of randomized controlled trials that compared neoadjuvant chemotherapy and surgery to surgery alone for resectable esophageal cancer [ J]. Am J Surg,2002, 183(3) :274 -279. 被引量:1
  • 9Fiorica F, Di Bona D, Schepis F, et al . Preoperative chemoradiotherapy for oesophageal cancer: a systematic review and meta-analysis [J]. Gut,2004,53(7):925-930. 被引量:1
  • 10Urschel JD, Vasan H. A meta-analysis of randomized controlled trials that compared neoadjuvant chemoradiation and surgery to surgery alone for resectable esophageal cancer [ J ]. Am J Surg, 2003,185 (6) :538 -543. 被引量:1

引证文献4

二级引证文献39

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部